Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19808924 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: AC2993 (exenatide);   Drug: daclizumab (immunosuppressive)

Indicates status has not been verified in more than two years